What is MOTS-c?
MOTS-c is named for a short open reading frame associated with the mitochondrial 12S ribosomal-RNA region. The literature's sequence-defined research material must be distinguished from a catalog label and from other mitochondrial-derived peptides. Identity, formulation and lot-specific analysis remain separate documentation questions for any supplied material.
What has mechanism research studied?
The 2015 study linked MOTS-c experiments with folate/purine metabolism and AMPK signaling in its models. The mechanistic interest is communication between mitochondrial genetic information and broader cellular metabolic responses, not a demonstrated universal increase in cellular energy.
The 2018 work investigated stress-associated nuclear localization and gene regulation, including an AMPK-dependent component. Subcellular movement and transcriptional changes provide experimentally testable hypotheses; they are not direct measures of organismal lifespan or a finished product's performance.
Bracketed identifiers refer to the papers in the source list below.
Findings worth reading closely
A mitochondrial-derived signaling candidate
Lee and colleagues described MOTS-c and reported changes in metabolic signaling and selected mouse metabolic outcomes.
Keep in view: The selected models cannot independently establish clinical outcomes or transferability to a different preparation.
Stress-associated nuclear communication
Kim and colleagues reported nuclear localization and changes in nuclear gene regulation associated with MOTS-c under metabolic stress.
Keep in view: Cellular localization and transcription endpoints need to be distinguished from whole-organism effects; pathway dependence is context-specific.
What remains unresolved?
- Which cellular contexts reproduce the same localization and signaling patterns? Cell type, stress model and measured compartment can change the research question.
- How does the sequence-defined experimental material compare with a supplied reference reagent in identity, content and formulation? A published name alone does not answer that question.
- Which downstream changes are required for the measured phenotype, rather than associated with it? Separating pathway activation from causal necessity makes the next experiment more informative.
- These selected papers do not constitute a comprehensive current trial review. They cannot establish human effectiveness, long-term safety, or an appropriate personal-use protocol, and none is proposed here.
Stability, storage & material identity
The cited signaling papers are not a universal storage specification. Use the documentation for the exact dry material or solution and preserve its formulation and lot identifiers.
Do not infer a shelf life or stability claim from a pathway study. A stability question requires its own conditions, sampling and suitable analytical method.
Check product-specific storage documentation →
Questions, answered.
Is MOTS-c a peptide or NAD+?
MOTS-c is a mitochondrial-derived peptide. NAD+ is a distinct coenzyme. Both appear in cellular-metabolism discussions, but a shared research context does not make them the same molecule or evidence base.
What does nuclear translocation establish?
The 2018 experiments support a model of stress-associated movement and gene regulation in the studied cells. They do not by themselves establish a clinical or longevity outcome.
Sources & reading notes
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Lee C et al. (2015)Source access: abstract.
- The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress · Kim KH, Son JM, Benayoun BA, Lee C (2018)Source access: abstract.
For research use only. Primary abstracts and identifiers checked November 1, 2026. Selected primary literature, not a systematic review. The 2018 paper discloses a consultant/shareholder relationship for one author; check its full conflict statement when appraising the study.